Navigation Links
Ellman's Pelleve™ Wrinkle Reduction System featured in "Sexy Eyes" segment on The Doctors
Date:11/28/2011

OCEANSIDE, N.Y., Nov. 28, 2011 /PRNewswire/ -- The Pelleve™ Wrinkle Reduction System was featured in a live demonstration on The Doctors on November 17th. Top dermatologist Dr. Ava Shamban of Santa Monica, CA performed the treatment, giving the audience and viewers a first-hand look at how Pelleve works. The treatment produced noticeable results in under an hour—less time than it takes to watch the show.

A revolutionary, non-ablative skin tightening system, Pelleve uses radiofrequency to provide a virtually pain free wrinkle reduction treatment that feels like a warm, relaxing massage. Although it is designed for use over the entire face, Dr Shamban demonstrated how Pelleve is especially good for treating around the eyes, giving brows a lift. Pelleve works by slowly heating the deep layers of the skin, creating new collagen, plumping up wrinkles, firming and tightening skin. There is no downtime and results last up to six months.

The hosts on The Doctors called Pelleve an "extremely exciting" new technology and a good way to "recapture a bit of your youth." Dr. Shamban says that a benefit of the device is that it delivers instant results, and though three sessions may be needed, the results improve with each consecutive treatment as Pelleve continues to stimulate the growth of more collagen. In the program, the patient, Sharon, experienced a 2mm lift in her brows, as well as in her eyelids.

To view The Doctor segment featuring Pelleve and view before and after images:
http://www.thedoctorstv.com/videolib/init/5298

About Ellman International

Founded in 1959, Ellman® International, Inc., a New York based manufacturer of devices for surgical and aesthetic procedures, remains recognized today as a pioneer in the development of specialized radiofrequency technology for precision cutting, coagulating, and tissue ablation in physician's offices and clinics. Ellman has a wide range of products that are used in aesthetic, surgical, dental and veterinary medicine in over 60 countries.  In 2009, the company leveraged the versatility of its unique radiofrequency platform to introduce the Pelleve™ Wrinkle Reduction System.  Pelleve is a revolutionary skin tightening system for non-ablative skin rejuvenation that can be performed in an hour or less, is virtually pain free and has minimal downtime for the patient.  Ellman introduced the Ellumine System, the latest innovation for fractional CO2 skin resurfacing, in late 2011.

For more information, visit www.ellman.com, www.pelleve.com and www.ellumine.com.

Find Pelleve at:
Facebook.com/pelleve
twitter.com/officialpelleve
twitter.com/pelleveskin

 


'/>"/>
SOURCE Ellman International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies
2. Looking Older Than You Are May Have Little to Do With Wrinkles
3. Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
4. Fibrocell Science, Inc. Receives FDA Complete Response Letter Regarding azficel-T for Wrinkles
5. NIST scientists address wrinkles in transparent film development
6. Ironing out the causes of wrinkles
7. Graphene: What can go wrong? new studies point to wrinkles, process contaminants
8. Nanowrinkles, nanofolds yield strange hidden channels
9. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
10. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
11. Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... WARRINGTON, Pa. , Feb. 3, 2016 /PRNewswire/ ... biotechnology company focused on developing aerosolized KL4 surfactant ... Board of Directors has approved an inducement award ... Craig Fraser , its newly appointed President and ... the Board,s Compensation Committee on February 1, 2016 ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... validating a series of potential targets (epitopes) specific to misfolded, propagating strains of ... to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the ...
Breaking Biology Technology:
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... VIEW, Calif. , Feb. 2, 2016 /PRNewswire/ ... retinopathy market, Frost & Sullivan recognizes US-based Intelligent ... America Frost & Sullivan Award for New Product ... provider in North America , ... in the rapidly growing diabetic retinopathy market. The ...
Breaking Biology News(10 mins):